Paper93585
Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse.
Clark EA and 3 others. Int J Cancer, 1979. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse. Papers, record 93585. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/93585
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody-Dependent Cell Cytotoxicity | Major topic |
| H-2 Antigens | Major topic |
| Killer Cells, Natural | Major topic |
| Mice, Inbred Strains | Major topic |
| Paramyxoviridae Infections | Major topic |
| Animals | |
| Cell Line | |
| Epitopes | |
| Female | |
| Genotype | |
| Leukemia, Experimental | |
| Lymphoma | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred CBA | |
| Mice, Nude | |
| Neoplasms, Experimental | |
| Parainfluenza Virus 1, Human | |
| Plasmacytoma |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31197363 | Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research. | ILAR J | 2018 | https://conductscience.org/library/papers/31197363 | PubMed |
| 9564563 | Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. | Clin Microbiol Rev | 1998 | https://conductscience.org/library/papers/9564563 | PubMed |
| 8101861 | Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. | J Exp Med | 1993 | https://conductscience.org/library/papers/8101861 | PubMed |
| 7203558 | Activation of natural killer (NK) cells in vivo with H-2 and non-H-2 alloantigens. | Immunogenetics | 1981 | https://conductscience.org/library/papers/7203558 | PubMed |
| 7185419 | Role of natural killer cells in control of cancer metastasis. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/7185419 | PubMed |
| 6971254 | Mutations in mice that influence natural killer (NK) cell activity. | Immunogenetics | 1981 | https://conductscience.org/library/papers/6971254 | PubMed |
| 6198116 | Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6198116 | PubMed |
| 6183763 | Natural killer cells in resistance to virus-infected cells. | Springer Semin Immunopathol | 1982 | https://conductscience.org/library/papers/6183763 | PubMed |
| 2821961 | Genetic determinants of lung virus titers and resistance to lethal Sendai virus pneumonia. | Arch Virol | 1987 | https://conductscience.org/library/papers/2821961 | PubMed |
| 2450688 | Regulation of natural killer activity. | Cancer Metastasis Rev | 1987 | https://conductscience.org/library/papers/2450688 | PubMed |
| 1850779 | Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. | J Exp Med | 1991 | https://conductscience.org/library/papers/1850779 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/93585
GET https://conductscience.org/api/papers/v1/93585/authors